Nuclear Science and Techniques

《核技术》(英文版) ISSN 1001-8042 CN 31-1559/TL     2019 Impact factor 1.556

Nuclear Science and Techniques ›› 2007, Vol. 18 ›› Issue (4): 223 doi: 10.1016/S1001-8042(07)60050-5

• RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICIN • Previous Articles     Next Articles

The preclinical pharmacological study of dopamine transporter imaging agent 18F-FP-β-CIT

LI Xiaomin1 CHEN Zhengping1* WANG Songpei1 TANG Jie1 LIN Yansong2 ZHU Zhaohui2 FANG Ping1   

  1. 1 Jiangsu Institute of Nuclear Medicine, Key Laboratory of Nuclear Medicine, Ministry of Health , Wuxi 214063, China;
    2 PET Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
PDF ShareIt Export Citation
LI Xiaomin CHEN Zhengping WANG Songpei TANG Jie LIN Yansong ZHU Zhaohui FANG Ping. The preclinical pharmacological study of dopamine transporter imaging agent 18F-FP-β-CIT.Nuclear Science and Techniques, 2007, 18(4): 223     doi: 10.1016/S1001-8042(07)60050-5
Citations
Altmetrics

Abstract: The paper is to study pharmacologic characteristics of 18F-FP-β-CIT (18F-N-(3-fluoropropyl)-2β- carbomethoxy- 3β- (4-iodophenyl)nortropane) as an imaging agent for dopamine transporter. The radiochemical purity of 18F-FP-β-CIT in aqueous solution was over 95% after standing at room temperature for 4h. Biodistribution displayed rapid uptake in rat brain (1.375 %ID/organ at 5min and 0.100 %ID/organ at 180 min) and the striatal uptake was 1.444, 0.731, 0.397, 0.230 and 0.146 %ID/g at 5, 30, 60, 120 and 180 min, respectively. The values of striatum/cerebellum, striatum /frontal cortex and striatum / hippocampus in rat’s brain at 30 min were 3.38, 2.17 and 2.40 respectively. The uptake in striatum can be blocked by β-CFT, suggesting that 18F-FP-β-CIT binds to DAT peculiarly. The compound was rapidly cleared from monkey’s blood. The striatal uptake was bilaterally decreased in the left-sided lesioned PD rats, compared with normal control. Brain PET imaging studies in normal monkey showed that 18F-FP-β-CIT was concentrated in striatum. The test of undue toxicity showed that the dose received by mice was 1250 times as by human, which indicates that 18F-FP-β-CIT is very safe. So 18F-FP-β-CIT is a promising PET imaging agent for DAT with safety and validity.

Key words: Parkinson’s disease, Dopamine transporter, Radionuclide imaging, 18F-FP-β-CIT, Biodistribution, Pharmacokinetics